Green, matcha, and black tea: Effective weapons against Omicron subvariants, research reveals

FHS
October 5, 2023
12:07 pm

The efficacy of tea and its catechins in deactivating the Omicron subvariant.

Enhancing patient engagement and outcomes in the NHS – Pharmaceutical Technology

Medication non-adherence is an enduring issue in the UK healthcare system, costing the NHS a staggering £930 million annually.[i] Despite advancements in medical treatments, adherence

January 14, 2025

Exploring the versatile roles of tissue macrophages beyond immune defense

The role of resident tissue macrophages (RTMs) in homeostasis and disease.

April 17, 2024

Good Response to Obesity Treatment in Childhood Improved Outcomes Down the Line

Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed.

January 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.